{
    "nct_id": "NCT06220214",
    "official_title": "Contrast Enhanced Digital Mammography for Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy",
    "inclusion_criteria": "* Diagnosis with either type of invasive locally advanced breast cancer regardless of hormone receptor or Her2 status\n* Plan to receive at least 4 cycles of neoadjuvant chemotherapy ahead of definitive surgery\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Pregnancy\n* Allergy/sensitivity to contrast agent\n* Decreased kidney function\n* Diabetes",
    "miscellaneous_criteria": ""
}